Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
University of Toronto
$120,000.00
Multiomic approaches to identify at-risk patients with thoracic aortic aneurysms
FY 2025-26
Summary
Thoracic aortic aneurysms (TAA) occur when part of the main blood vessel carrying blood from the heart (the aorta) becomes enlarged and balloons out. TAA affects up to 1 in 1000 people and can grow silently for years. The greatest danger is when an aneurysm suddenly tears, called an acute type A dissection (ATAD), which can be deadly. Surgery to fix the aneurysm can prevent ATAD, but it is a major surgery and carries its own risks. Predicting who is most at risk for dissection remains difficult. Currently, doctors mainly use the aorta's size and its yearly change to guide decisions, but this is unreliable - almost half of ATAD happens in people with aneurysms smaller than the recommended size.
Our group has studied aneurysms for the past few years using samples of aorta and blood from patients having surgery. We found certain proteins which are different between patients with aneurysms and dissections compared to those without. Many are involved in the cell's structural framework. In mice, we found that inactivating one of these proteins, cortactin, led to earlier death from disection compared to normal mice.
In this project, our goal is to find blood markers to help doctors identify which patients are at high risk of their aneurysms growing or dissecting so that treatment can be given at the right time, while avoiding unnecessary surgery for those at low risk. We have a three-step plan towards this goal:
Aim 1: Find which proteins are linked to fast-growing aneurysms. We will compare proteins from blood and aorta samples of patients with aneurysms being followed in a clinical trial.
Aim 2: Grouped patients based on protein levels, medical history and sex (male or female) and age to see whether any subtypes of aneurysms and "protein signatures" (patterns in levels of specific proteins) might be linked with faster growth or higher chance of ATAD.
Aim 3: Use computer modelling to develop a risk score based on a blood test and medical data.
Department
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
559695
Name
Hu Mostin AIyu
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Multiomic approaches to identify at-risk patients with thoracic aortic aneurysms
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Acute Aortic Dissection; Aortic Aneurysm; Bioinformatics; Computational Biology; Proteomics; Risk Prediction; Thoracic Aortic Aneurysm
Abstract
Thoracic aortic aneurysms (TAA) occur when part of the main blood vessel carrying blood from the heart (the aorta) becomes enlarged and balloons out. TAA affects up to 1 in 1000 people and can grow silently for years. The greatest danger is when an aneurysm suddenly tears, called an acute type A dissection (ATAD), which can be deadly. Surgery to fix the aneurysm can prevent ATAD, but it is a major surgery and carries its own risks. Predicting who is most at risk for dissection remains difficult. Currently, doctors mainly use the aorta's size and its yearly change to guide decisions, but this is unreliable - almost half of ATAD happens in people with aneurysms smaller than the recommended size.
Our group has studied aneurysms for the past few years using samples of aorta and blood from patients having surgery. We found certain proteins which are different between patients with aneurysms and dissections compared to those without. Many are involved in the cell's structural framework. In mice, we found that inactivating one of these proteins, cortactin, led to earlier death from disection compared to normal mice.
In this project, our goal is to find blood markers to help doctors identify which patients are at high risk of their aneurysms growing or dissecting so that treatment can be given at the right time, while avoiding unnecessary surgery for those at low risk. We have a three-step plan towards this goal:
Aim 1: Find which proteins are linked to fast-growing aneurysms. We will compare proteins from blood and aorta samples of patients with aneurysms being followed in a clinical trial.
Aim 2: Grouped patients based on protein levels, medical history and sex (male or female) and age to see whether any subtypes of aneurysms and "protein signatures" (patterns in levels of specific proteins) might be linked with faster growth or higher chance of ATAD.
Aim 3: Use computer modelling to develop a risk score based on a blood test and medical data.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Hu, Mostin AIyu
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~